Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ABBOTT LABORATORIES

(ABT)
  Report
Delayed Nyse  -  01:02 2022-11-25 pm EST
106.96 USD   +0.89%
11/25Ypsomed, CamDiab Roll Out Automated Insulin Dosing on Abbott's Glucose Monitoring System
MT
11/21Abbott Launches Panbio HIV Self Test at Retail, Increasing Access to Faster, Reliable and Discrete Testing at Home
CI
11/17Abbott Receives Three CES 2023 Innovation Awards for Advancements in Health Technology
PR
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Abbott Hosts Conference Call for Third-Quarter Earnings

09/28/2022 | 09:01am EST

ABBOTT PARK, Ill., Sept. 28, 2022 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its third-quarter 2022 financial results on Wednesday, Oct. 19, 2022, before the market opens.

The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern), and will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the call will be available later that day.

About Abbott:
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 113,000 colleagues serve people in more than 160 countries.

Connect with us at www.abbott.com, on LinkedIn at www.linkedin.com/company/abbott-/, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews.

 

Cision
View original content:https://www.prnewswire.com/news-releases/abbott-hosts-conference-call-for-third-quarter-earnings-301635456.html

SOURCE Abbott


ę PRNewswire 2022
All news about ABBOTT LABORATORIES
11/25Ypsomed, CamDiab Roll Out Automated Insulin Dosing on Abbott's Glucose Monitoring Syste..
MT
11/21Abbott Launches Panbio HIV Self Test at Retail, Increasing Access to Faster, Reliable a..
CI
11/17Abbott Receives Three CES 2023 Innovation Awards for Advancements in Health Technology
PR
11/10Becton Dickinson expects fiscal 2023 COVID test sales to drag
RE
11/07MedTech Market Leaders Share Their Long-Term Business Strategy at CECP's CEO Investor F..
AQ
11/02NZ's a2 Milk gets temporary approval to export infant milk formula to U.S
RE
11/01ABBOTT LABORATORIES Management's Discussion and Analysis of Financial Condition and Re..
AQ
11/01Baby formula maker Perrigo buying Nestle's Good Start brand, Wisconsin plant
RE
10/26Mizuho Starts Abbott Laboratories at Neutral With $105 Price Target
MT
10/26Reckitt upbeat on sales outlook as prices rise
RE
More news
Analyst Recommendations on ABBOTT LABORATORIES
More recommendations